# Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy

> **NCT05507697** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Wuhan Central Hospital** · enrollment: 42 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy Type 2

## Interventions

- **BIOLOGICAL:** HUC-MSCs
- **BIOLOGICAL:** Lipoic Acid

## Key facts

- **NCT ID:** NCT05507697
- **Lead sponsor:** Wuhan Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-19
- **Primary completion:** 2024-05-18
- **Final completion:** 2024-05-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05507697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05507697, "Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05507697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*